VigoritoCAbreuAAmbrosettiMet al.Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac Rehabilitation Section. Eur J Prev Cardiol2017; 24: 577–590.
2.
RibeiroGSMeloRDDereszLFet al.Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 688–697.
3.
PresslerAFörschnerLHummelJet al.Long-term effect of exercise training in patients after transcatheter aortic valve implantation: Follow-up of the SPORT:TAVI randomised pilot study. Eur J Prev Cardiol2018; 25: 794–801.
GongWLiAAiHet al.Safety of early discharge after primary angioplasty in low-risk patients with ST-segment elevation myocardial infarction: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol2018; 25: 807–815.
6.
VidaleSCampanaC. Ambient air pollution and cardiovascular diseases: From bench to bedside. Eur J Prev Cardiol2018; 25: 818–825.
7.
YangWYZhangZYThijsLet al.Left ventricular function in relation to chronic residential air pollution in a general population. Eur J Prev Cardiol2017; 24: 1416–1428.
8.
AkintoyeEShiLObaitanIet al.Association between fine particulate matter exposure and subclinical atherosclerosis: A meta-analysis. Eur J Prev Cardiol2016; 23: 602–612.
9.
ChuPRinskeAGotinkRAet al.The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol2016; 23: 291–307.
10.
KhanSUTalluriSRiazHet al.A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes. Eur J Prev Cardiol2018; 25: 844–853.
11.
SkielboeAKMarottJLDixenUet al.Occupational physical activity, but not leisure-time physical activity increases the risk of atrial fibrillation: The Copenhagen City Heart Study. Eur J Prev Cardiol2016; 23: 1883–1893.
12.
RicciCGervasiFGaetaMet al.Physical activity volume in relation to risk of atrial fibrillation: A nonlinear meta-regression analysis. Eur J Prev Cardiol2018; 25: 857–866.
13.
PiepoliMFHoesAWAgewallSet al.European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol2016; 23: NP1–NP96.
14.
SchonmannYBleichOMatalonAet al.Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort. Eur J Prev Cardiol2018; 25: 870–880.
15.
WeiXBLiuYHHePCet al.Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis. Eur J Prev Cardiol2017; 24: 676–684.
16.
MjelvaØRPonitzVBrugger-AndersenTet al.Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. Eur J Prev Cardiol2016; 23: 1130–1140.
17.
ArzilliCAimoAVergaroGet al.N-terminal fraction of pro-B-type natriuretic peptide vs. clinical risk scores for prognostic stratification in chronic systolic heart failure. Eur J Prev Cardiol2018; 25: 889–895.